Kamada (KMDA) Cash from Operations Growth (3y) (2015 - 2026)
Kamada (KMDA) Cash from Operations Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 34.90% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -9.94% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -10.80% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 7.32% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -26.33% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn | 46.81% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 27.85% |
| 10 | Kamada | 400.07 Mn | 326.92 Mn | 19.12 Mn | -367.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -367.34% |
| Dec 31, 2025 | 939.18% |
| Sep 30, 2025 | 1,137.82% |
| Jun 30, 2025 | -9.68% |
| Mar 31, 2025 | -27.93% |
| Dec 31, 2024 | 1,179.48% |
| Sep 30, 2024 | 117.67% |
| Jun 30, 2024 | 84.27% |
| Mar 31, 2024 | -21.42% |
| Dec 31, 2023 | -21.74% |
| Sep 30, 2023 | -27.15% |
| Jun 30, 2023 | -44.54% |
| Mar 31, 2023 | 88.59% |
| Dec 31, 2022 | -90.80% |
| Sep 30, 2022 | -90.34% |
| Jun 30, 2022 | 17.23% |
| Mar 31, 2022 | -3.39% |
| Dec 31, 2021 | -26.01% |
| Sep 30, 2021 | -65.94% |
| Jun 30, 2021 | -12.46% |